Ginkgo Bioworks
Company Snapshot
Company Overview
Founded in 2008 as a spinout from the Massachusetts Institute of Technology, Ginkgo Bioworks designs and operates production systems using designed organisms. Ginkgo develops organisms that can produce a range of products, including flavors and fragrances, industrial enzymes, nutritional ingredients, cosmetics, sweeteners, and pharmaceuticals.
Ginkgo works with companies in end-product areas to design microorganisms and develop a production method for creating the product. Ginkgo derives revenues from royalties on product sales.
End-use customers with whom Ginkgo works include Ajinomoto (food and pharmaceuticals) and Robertet (flavor and fragrances).
Robertet’s objective in working with Ginkgo is to develop a less expensive and less time-consuming path to producing a rose scent. The current method of doing this is to squeeze oils from the rose flowers’ petals. Ginkgo will also work on apricot, coconut, and mango fragrances in alliance with Robertet.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Company's Business Segments
- Cell Engineering : This segment includes research and development services performed under collaboration and license agreements relating to the company's cell programming platform.
- Biosecurity : This segment consists of end-to-end biomonitoring and bioinformatic support services primarily provided to public health authorities.
Applications/End User Industries
- Biopharma
- Biotechnology
- Government
- Nutrition & Wellness
- Agriculture
- Biosecurity
- Industrial